Diamyd Medical

Diamyd Medical

Sweden - Stockholm
Biotechnology
WebsiteLinkedInCareers Page

Focus: Diabetes-Targeting Biologics

Diamyd Medical is a life sciences company focused on Diabetes-Targeting Biologics.

Metabolic Diseases
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT02352974GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)
Phase 1
Gamma-Aminobutyric Acid
Type 1 Diabetes Mellitus
Phase 1/2
Clinical Trials (1)
NCT03635437Evaluation of Safety and Diabetes Status Upon Oral Treatment With GABA in Patients With Longstanding Type-1 Diabetes
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT05351879Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes
Phase 1/2
recombinant human glutamic acid dehydrogenase
Latent Autoimmune Diabetes in Adults
Phase 2
Clinical Trials (1)
NCT04262479Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes
Phase 2
Phase 2
Clinical Trials (1)
NCT01785108DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen
Phase 2
Phase 2
Clinical Trials (1)
NCT05683990Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes
Phase 2
Phase 2
Clinical Trials (1)
NCT03345004Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes
Phase 2
Phase 2
Clinical Trials (1)
NCT02464033EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes
Phase 2
Recombinant human glutamic acid decarboxylase
Type 1 Diabetes Mellitus
Phase 3
Clinical Trials (1)
NCT05018585A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes
Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 9 clinical trials
Top TAs: Metabolic Diseases, Immunology, Endocrinology
Publications: 8 in PubMed
Therapeutic Area Focus
Immunology
3 pipeline
Endocrinology
1 pipeline
Marketed
Pipeline